Publication | Open Access
Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models
74
Citations
27
References
2016
Year
Metformin may potentially enhance the effect of sorafenib to inhibit HCC recurrence and metastasis after liver resection by regulating the expression of HIF-2α and TIP30.
| Year | Citations | |
|---|---|---|
Page 1
Page 1